Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.

  title={Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.},
  author={John A Zaia},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  volume={35 8},
  • John A Zaia
  • Published 2002 in
    Clinical infectious diseases : an official…
Prevention of cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) generally involves preemptive treatment of recognized infection before the onset of overt CMV-associated disease. The success of this method depends on efficient recognition of infection and intervention before the disease progresses. Reliable tests for such diagnosis include blood culture, antigenemia assays, polymerase chain reaction assays, and other DNA sequence- or RNA sequence-based assays… CONTINUE READING
16 Citations
60 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 16 extracted citations


Publications referenced by this paper.
Showing 1-10 of 60 references

Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogenic stem cell transplantation

  • H Hebart, T Rudolf, J Loeffler
  • Bone Marrow Transplant
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…